AU Labs, a specialized company based on nanogold composite materials, announced on the 31st that it has appointed Executive Director Ki-Hyeon Park as its new Chief Operating Officer (COO) and is embarking on full-scale business expansion.
New COO Park Ki-hyun has extensive experience overseeing management planning, business development, and future strategy at major domestic healthcare companies, including Chong Kun Dang and Kolmar Korea. Notably, he spearheaded the initial public offering (IPO) of HEM Pharma (376290), which successfully listed on KOSDAQ last year, and has experience leading the development of health functional foods and pharmaceuticals. AU Labs explained that this appointment was made in recognition of his management and execution capabilities.
AYLABS has launched cosmetics based on its proprietary core ingredient, niacin gold, and plans to expand its business into health functional foods and pharmaceuticals. CEO Lee Ji-sang stated, "Following the initial stabilization of our cosmetics business, we are now actively pursuing strategic business diversification. The addition of Executive Director Park Ki-hyun, with his comprehensive industry understanding and planning capabilities, is highly significant."
With this appointment, AYLABS plans to pursue a multi-faceted growth strategy, including strengthening its organizational operational capabilities, expanding its external collaboration network, developing new pipelines, and expanding its B2B business.
Founded in 2020, AU Labs has developed and launched functional cosmetics based on "Niacin Gold," a combination of gold nanoparticles and niacinamide. Building on its patented composition, the company is exploring expansion into the bio-healthcare sector, including health supplements and pharmaceuticals, beyond cosmetics. Recently, the company is also considering an initial public offering (IPO) as part of its mid- to long-term growth strategy.
You must be logged in to post a comment.